Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of “Moderate Buy” by Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has earned a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $27.1111.

A number of research firms have recently issued reports on SGRY. Cantor Fitzgerald reissued an “overweight” rating and issued a $36.00 price target on shares of Surgery Partners in a research note on Tuesday, October 7th. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $27.00 to $20.00 and set a “neutral” rating for the company in a report on Monday, November 24th. Royal Bank Of Canada reduced their target price on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a report on Tuesday, November 11th. Benchmark dropped their price target on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating for the company in a research note on Tuesday, November 11th. Finally, Barclays cut their price objective on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Friday, November 21st.

Hedge Funds Weigh In On Surgery Partners

Several hedge funds and other institutional investors have recently made changes to their positions in SGRY. Russell Investments Group Ltd. increased its position in shares of Surgery Partners by 241.0% in the 1st quarter. Russell Investments Group Ltd. now owns 21,257 shares of the company’s stock valued at $505,000 after purchasing an additional 15,024 shares during the last quarter. Raymond James Financial Inc. raised its stake in Surgery Partners by 24.8% in the first quarter. Raymond James Financial Inc. now owns 597,162 shares of the company’s stock valued at $14,183,000 after buying an additional 118,674 shares in the last quarter. AlphaQuest LLC raised its position in shares of Surgery Partners by 112.0% during the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock worth $25,000 after acquiring an additional 559 shares in the last quarter. Jump Financial LLC acquired a new stake in shares of Surgery Partners during the 1st quarter worth about $363,000. Finally, MetLife Investment Management LLC lifted its position in shares of Surgery Partners by 715.8% during the 1st quarter. MetLife Investment Management LLC now owns 383,642 shares of the company’s stock worth $9,111,000 after buying an additional 336,615 shares during the last quarter.

Surgery Partners Stock Performance

Surgery Partners stock opened at $15.53 on Wednesday. The firm has a 50 day simple moving average of $18.19 and a 200-day simple moving average of $20.67. The stock has a market cap of $2.01 billion, a price-to-earnings ratio of -11.42 and a beta of 1.93. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.88 and a quick ratio of 1.72. Surgery Partners has a 1-year low of $14.94 and a 1-year high of $26.16.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Monday, November 10th. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The business had revenue of $821.50 million during the quarter, compared to analyst estimates of $823.55 million. Surgery Partners had a negative net margin of 5.21% and a positive return on equity of 2.41%. The company’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.19 earnings per share. On average, analysts expect that Surgery Partners will post 0.67 EPS for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.